Back

Plasma protein biomarkers for the early detection of gastric preneoplasia and cancer: a prospective study

Gianetto, Q. G.; Michel, V.; Douche, T.; Nozeret, K.; Zaanan, A.; Colussi, O.; Trouilloud, I.; Pernot, S.; Ungeheuer, M.-N.; Julie, C.; Jolly, N.; Taieb, J.; Lamarque, D.; Matondo, M.; Touati, E.

2025-04-30 cancer biology
10.1101/2025.04.29.651246 bioRxiv
Show abstract

Gastric cancer (GC) often presents a poor prognosis due to its asymptomatic phenotype at early stages. Upper endoscopy, the current gold standard for diagnosis, is invasive with limited sensitivity for detecting gastric preneoplasia. Non-invasive biomarkers, such as blood circulating proteins offer a promising alternative for an early detection. Using mass spectrometry-based proteomics we identified plasma proteins as biomarkers of the presence of gastric preneoplasia and cancer lesions in an exploratory subgroup of patients (n=39). Fifteen promising protein candidates emerged to distinguish patient categories and were further confirmed by enzyme-linked immunosorbent assays (ELISA) in plasma samples from a cohort of 138 participants. Our predictive models demonstrated high classification performance with a minimal set of biomarkers, making them clinically applicable. Repeated cross-validations yielded high Area Under the Receiver Operating Characteristics (AUROC) values, notably distinguishing cancerous or precancerous cases from non-cancerous ones. Leveraging simple blood sampling, this strategy holds promise to detect high-risk gastric lesions, even at asymptomatic stages. Such an approach could significantly improve early detection and clinical management of GC, offering direct benefit for patients.

Published in International Journal of Molecular Sciences (predicted rank #10) · training set

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above